Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.

Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y.

Clin Rev Allergy Immunol. 2011 Oct;41(2):163-8. doi: 10.1007/s12016-010-8212-4. Review.

PMID:
20882368
2.

Macrophagic myofasciitis: characterization and pathophysiology.

Gherardi RK, Authier FJ.

Lupus. 2012 Feb;21(2):184-9. doi: 10.1177/0961203311429557.

3.

Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study.

Ragunathan-Thangarajah N, Le Beller C, Boutouyrie P, Bassez G, Gherardi RK, Laurent S, Authier FJ.

J Inorg Biochem. 2013 Nov;128:262-6. doi: 10.1016/j.jinorgbio.2013.07.020. Epub 2013 Jul 20.

PMID:
23921285
4.

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.

Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, Pellissier JF, Chariot P, Authier FJ.

Brain. 2001 Sep;124(Pt 9):1821-31.

PMID:
11522584
5.

[Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].

Gherardi RK.

Rev Neurol (Paris). 2003 Feb;159(2):162-4. Review. French.

PMID:
12660567
6.

[Vaccine adjuvants and macrophagic myofasciitis].

Siegrist CA.

Bull Acad Natl Med. 2003;187(8):1511-8; discussion 1519-21. Review. French.

PMID:
15146582
7.

[Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?].

Gherardi RK, Cadusseau J, Authier FJ.

Bull Acad Natl Med. 2014 Jan;198(1):37-48; discussion 49-53. French.

PMID:
26259285
8.

Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.

Brenner A.

Vaccine. 2002 May 31;20 Suppl 3:S5-6.

PMID:
12184366
9.

Macrophagic myofasciitis and vaccination: consequence or coincidence?

Santiago T, Rebelo O, Negrão L, Matos A.

Rheumatol Int. 2015 Jan;35(1):189-92. doi: 10.1007/s00296-014-3065-4. Epub 2014 Jun 13.

PMID:
24923906
10.

Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.

Gherardi RK, Aouizerate J, Cadusseau J, Yara S, Authier FJ.

Morphologie. 2016 Jun;100(329):85-94. doi: 10.1016/j.morpho.2016.01.002. Epub 2016 Apr 6. Review.

PMID:
26948677
11.

Polyglandular autoimmunity with macrophagic myofasciitis.

Theeler BJ, Simper NB, Ney JP.

Clin Rheumatol. 2008 May;27(5):667-9. doi: 10.1007/s10067-007-0793-9. Epub 2008 Jan 8.

PMID:
18180978
12.

Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum.

Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Jara LJ, Shoenfeld Y.

Expert Rev Clin Immunol. 2013 Apr;9(4):361-73. doi: 10.1586/eci.13.2. Review.

PMID:
23557271
13.

Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.

Chkheidze R, Burns DK, White CL, Castro D, Fuller J, Cai C.

J Neuropathol Exp Neurol. 2017 Apr 1;76(4):323-331. doi: 10.1093/jnen/nlx011.

14.

['ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants: even and odd].

Perricone C, Alessandri C, Valesini G.

Reumatismo. 2011;63(2):63-6. Italian.

15.

Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition.

Eidi H, David MO, Crépeaux G, Henry L, Joshi V, Berger MH, Sennour M, Cadusseau J, Gherardi RK, Curmi PA.

BMC Med. 2015 Jun 17;13:144. doi: 10.1186/s12916-015-0388-2.

16.

'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.

Shoenfeld Y, Agmon-Levin N.

J Autoimmun. 2011 Feb;36(1):4-8. doi: 10.1016/j.jaut.2010.07.003. Epub 2010 Aug 13. Review.

PMID:
20708902
17.

Atypical presentation of macrophagic myofasciitis 10 years post vaccination.

Ryan AM, Bermingham N, Harrington HJ, Keohane C.

Neuromuscul Disord. 2006 Dec;16(12):867-9. Epub 2006 Sep 26.

PMID:
17005400
18.

Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile.

Aoun Sebaiti M, Kauv P, Charles-Nelson A, Van Der Gucht A, Blanc-Durand P, Itti E, Gherardi RK, Bachoud-Levi AC, Authier FJ.

J Inorg Biochem. 2018 Apr;181:132-138. doi: 10.1016/j.jinorgbio.2017.09.019. Epub 2017 Oct 6.

PMID:
29079320
19.

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.

Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y.

J Autoimmun. 2013 Dec;47:1-16. doi: 10.1016/j.jaut.2013.10.004. Epub 2013 Nov 13. Review.

PMID:
24238833
20.

Central nervous system disease in patients with macrophagic myofasciitis.

Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD, Gherardi RK.

Brain. 2001 May;124(Pt 5):974-83.

PMID:
11335699

Supplemental Content

Support Center